Myriad Genetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. 

CEO
Samraat S Raha
CEOSamraat S Raha
Employees
2,700
Employees2,700
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1991
Founded1991
Employees
2,700
Employees2,700

MYGN Key Statistics

Market cap
565.74M
Market cap565.74M
Price-Earnings ratio
-1.39
Price-Earnings ratio-1.39
Dividend yield
Dividend yield
Average volume
2.06M
Average volume2.06M
High today
$6.12
High today$6.12
Low today
$5.92
Low today$5.92
Open price
$6.05
Open price$6.05
Volume
1.20M
Volume1.20M
52 Week high
$8.59
52 Week high$8.59
52 Week low
$3.53
52 Week low$3.53

Stock Snapshot

With a market cap of 565.74M, Myriad Genetics(MYGN) trades at $5.99. The stock has a price-to-earnings ratio of -1.39.

During the trading session on 2026-07-06, Myriad Genetics(MYGN) shares reached a daily high of $6.12 and a low of $5.92. At a current price of $5.99, the stock is +1.2% higher than the low and still -2.1% under the high.

Trading volume for Myriad Genetics(MYGN) stock has reached 1.2M, versus its average volume of 2.06M.

The stock's 52-week range extends from a low of $3.53 to a high of $8.59.

The stock's 52-week range extends from a low of $3.53 to a high of $8.59.

MYGN News

TipRanks 6d
Sera Prognostics Adds Veteran Executive to Board

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Nasdaq 7d
Myriad Soars 8.3%: Is Further Upside Left in the Stock?

Myriad Genetics MYGN shares rallied 8.3% in the last trading session to close at $5.88. This move can be attributable to notable volume with a higher number of...

Myriad Soars 8.3%: Is Further Upside Left in the Stock?

Analyst ratings

56%

of 9 ratings
Buy
22.2%
Hold
55.6%
Sell
22.2%

People also own

Based on the portfolios of people who own MYGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.